Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 47101-47150 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05100342
Prospective Validation of a Points Score System Predicting 30-day Survival
N/A
Recruiting
114 participants
Started: Sep 12, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
3 locations
NCT05387863
Decision Aid (DA) for Renal Patients
NA
Recruiting
40 participants
Started: Sep 12, 2022 · Completed: Jun 30, 2025
2 conditions
1 sponsor
1 location
NCT06080919
Plaque Modification And Impact On Microcirculatory Territory After Drug-Coated Balloon Percutaneous Coronary Intervention (PLAMI).
NA
Recruiting
30 participants
Started: Sep 12, 2022 · Completed: May 31, 2024
6 conditions
1 sponsor
1 location
NCT05465174
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
PHASE2
Recruiting
57 participants
Started: Sep 12, 2022 · Completed: Mar 1, 2028
3 conditions
2 sponsors
14 locations
NCT05454267
Early Detection of Vaping-related Vascular Diseases
N/A
Recruiting
90 participants
Started: Sep 12, 2022 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT05544136
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
PHASE2
Recruiting
12 participants
Started: Sep 12, 2022 · Completed: Mar 12, 2027
4 conditions
1 sponsor
6 locations
NCT04098146
Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis
N/A
Recruiting
300 participants
Started: Sep 12, 2022 · Completed: Dec 31, 2030
2 conditions
1 sponsor
19 locations
NCT04541992
Sensors Prediction Study
N/A
Recruiting
8,300 participants
Started: Sep 12, 2022 · Completed: Sep 30, 2025
1 condition
4 sponsors
1 location
NCT05219201
Effectiveness of Cryotherapy on the Fatigue of Patients With Multiple Sclerosis
NA
Recruiting
80 participants
Started: Sep 12, 2022 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT05412862
Positive Emotions Following Acute Cardiac Events
NA
Recruiting
280 participants
Started: Sep 12, 2022 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT06273059
Genomic Study of Young-Onset Diabetes Mellitus
N/A
Recruiting
1,000 participants
Started: Sep 12, 2022 · Completed: Dec 12, 2024
3 conditions
1 sponsor
1 location
NCT05621278
Children to Adults Mental and Psychosomatic Health Study (CAMPS)
N/A
Recruiting
400,000 participants
Started: Sep 11, 2022 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05531123
Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer
PHASE2
Recruiting
30 participants
Started: Sep 10, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05442827
A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine Fibroids
PHASE2/PHASE3
Recruiting
357 participants
Started: Sep 10, 2022 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT05502367
A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia
PHASE1/PHASE2
Recruiting
110 participants
Started: Sep 10, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
7 locations
NCT05392764
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
PHASE3
Recruiting
524 participants
Started: Sep 10, 2022 · Completed: Dec 31, 2027
1 condition
2 sponsors
61 locations
NCT04728724
Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer
PHASE2
Recruiting
100 participants
Started: Sep 10, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05176418
IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate
EARLY_PHASE1
Recruiting
70 participants
Started: Sep 9, 2022 · Completed: Feb 1, 2026
1 condition
1 sponsor
1 location
NCT05152368
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells Exosomes for Trigeminal Neuralgia
PHASE1
Recruiting
20 participants
Started: Sep 9, 2022 · Completed: Jan 31, 2026
2 conditions
1 sponsor
1 location
NCT06154915
Immune Cells in Diabetic Chronic Foot Ulcers
N/A
Recruiting
40 participants
Started: Sep 9, 2022 · Completed: Dec 31, 2029
2 conditions
1 sponsor
1 location
NCT05596474
Effect of Beet-root Juice and PBM Treatments on Muscle Fatigue
NA
Recruiting
10 participants
Started: Sep 9, 2022 · Completed: Aug 31, 2024
2 conditions
1 sponsor
1 location
NCT05547607
Clinical and Diagnostic Features of Endocarditis
N/A
Recruiting
500 participants
Started: Sep 9, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT05400122
Natural Killer (NK) Cells in Combination with Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
PHASE1
Recruiting
12 participants
Started: Sep 9, 2022 · Completed: Jun 1, 2026
18 conditions
1 sponsor
1 location
NCT06223308
A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
54 participants
Started: Sep 9, 2022 · Completed: Oct 1, 2024
2 conditions
1 sponsor
1 location
NCT05370391
Comprehensive Behavioral Intervention for Tics
NA
Recruiting
200 participants
Started: Sep 9, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT05540340
A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant
PHASE1
Recruiting
40 participants
Started: Sep 9, 2022 · Completed: Sep 30, 2026
5 conditions
1 sponsor
1 location
NCT05613023
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
PHASE3
Recruiting
1,128 participants
Started: Sep 9, 2022 · Completed: Jun 30, 2030
1 condition
2 sponsors
42 locations
NCT06704230
Stress Reduction Using Video Googles on Patients Undergoing Vascular Surgery
NA
Recruiting
100 participants
Started: Sep 9, 2022 · Completed: Apr 30, 2025
3 conditions
2 sponsors
1 location
NCT05414058
Adjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive Outcomes
PHASE2
Recruiting
24 participants
Started: Sep 9, 2022 · Completed: Sep 9, 2025
1 condition
1 sponsor
1 location
NCT05691608
MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2
NA
Recruiting
1,800 participants
Started: Sep 9, 2022 · Completed: Sep 9, 2030
2 conditions
1 sponsor
29 locations
NCT05480696
Soluble Fibre Supplementation in NAFLD
PHASE2
Recruiting
60 participants
Started: Sep 9, 2022 · Completed: Mar 31, 2027
3 conditions
1 sponsor
1 location
NCT03832127
Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients
PHASE1
Recruiting
35 participants
Started: Sep 9, 2022 · Completed: Sep 9, 2026
1 condition
2 sponsors
7 locations
NCT05346796
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
NA
Recruiting
250 participants
Started: Sep 9, 2022 · Completed: May 31, 2027
1 condition
2 sponsors
1 location
NCT05650307
CV Imaging of Metabolic Interventions
N/A
Recruiting
150 participants
Started: Sep 9, 2022 · Completed: Sep 9, 2027
3 conditions
1 sponsor
1 location
NCT05654272
Development of CIRC Technologies
N/A
Recruiting
1,000 participants
Started: Sep 9, 2022 · Completed: Sep 9, 2042
10 conditions
1 sponsor
1 location
NCT06162897
Case Management Dyad
NA
Recruiting
180 participants
Started: Sep 9, 2022 · Completed: Jun 30, 2027
3 conditions
2 sponsors
1 location
NCT05498662
An Observational Study of the T3 Pro Dental Implant System
N/A
Recruiting
60 participants
Started: Sep 8, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
2 locations
NCT05042375
A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer
PHASE3
Recruiting
450 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
80 locations
NCT05418049
Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge
PHASE2
Recruiting
45 participants
Started: Sep 8, 2022 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT05279092
Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study
PHASE2
Recruiting
250 participants
Started: Sep 8, 2022 · Completed: Mar 31, 2028
2 conditions
2 sponsors
2 locations
NCT05394506
Modifying Factors in Striated Muscle Laminopathies
NA
Recruiting
40 participants
Started: Sep 8, 2022 · Completed: Dec 30, 2027
4 conditions
1 sponsor
8 locations
NCT06511856
FH ORTHO Shoulder Observatory
N/A
Recruiting
500 participants
Started: Sep 8, 2022 · Completed: Sep 8, 2035
2 conditions
1 sponsor
3 locations
NCT06506084
Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)
N/A
Recruiting
319 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
37 locations
NCT05576948
Natural History of Cerebral Palsy Prospective Study
N/A
Recruiting
100 participants
Started: Sep 8, 2022 · Completed: Sep 8, 2027
1 condition
2 sponsors
1 location
NCT05549713
The Effect of Upper Blepharoplasty on Vision Quality in the Early Postoperative Period
N/A
Recruiting
40 participants
Started: Sep 8, 2022 · Completed: Jan 1, 2026
4 conditions
1 sponsor
1 location
NCT04963751
ERAS in Pediatric & Adolescent Gynecology Preoperative Counseling
NA
Recruiting
60 participants
Started: Sep 8, 2022 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT05443451
BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY
NA
Recruiting
12 participants
Started: Sep 8, 2022 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT05347550
Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients
NA
Recruiting
21,472 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2025
1 condition
3 sponsors
9 locations
NCT05553873
Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.
N/A
Recruiting
500 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
11 locations
NCT05667610
Immune-supportive Diet and Gut Permeability in Allergic Children
NA
Recruiting
132 participants
Started: Sep 8, 2022 · Completed: Jun 30, 2027
2 conditions
11 sponsors
1 location
Previous
1
More pages
940
941
942
943
944
945
946
More pages
1333
Next